CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Samjin Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Samjin Pharmaceutical Co Ltd
121, Wausan-ro, Mapo-gu
Phone: +82 231400700p:+82 231400700 SEOUL, 04054  South Korea Ticker: 005500005500
Business Summary
Samjin Pharmaceuticals co., LTD. is a Korea-based company mainly engaged in the manufacture of pharmaceutical products. The Company’s products include antipyretics, analgesics, antiphlogistic agents, osteoarthritis agents, osteopathic agents, antihistaminic agents, circulatory system drugs, gastrointestinal agents, osteoporosis treatments, hepatic disease agents, respiratory agents, antibiotics agents, detoxifying agents, antifungal agents, antineoplastic agents and others. Its products are provided in the forms of tablets, injections, capsules and others. It distributes its products to the hospitals and drugstores. The Company supplies its products within domestic market and to overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Co-Chairman Ui HwanCho 81 1/1/2021
Co-Chairman Seung JuChoi 80 1/1/2021
Co-President, Co-Chief Executive Officer, Director Yong JuChoi 65 1/1/2021 3/22/2019
11 additional Officers and Directors records available in full report.

Business Names
Business Name
005500
Samjin Pharmaceutical Co., Ltd.

General Information
Number of Employees: 781 (As of 12/31/2023)
Outstanding Shares: 12,774,964 (As of 12/31/2023)
Shareholders: 12,097
Stock Exchange: KRX
Fax Number: +82 23925312


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024